Article info
Methods
Review
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
- Correspondence to Dr Xiao-Jie Lu, Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210009, China; 189{at}whu.edu.cn
Citation
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
Publication history
- Received April 12, 2018
- Revised May 1, 2018
- Accepted May 16, 2018
- First published July 3, 2018.
Online issue publication
December 13, 2018
Article Versions
- Previous version (13 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.